GlassScriptPhysician profile
Maria Baldasare
NPI 1790914372
$8,986.21
in general payments reported to CMS, 2019-2025
26 companies · $3,676 in 2025
The $3,676 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,934 · 2020: $290 · 2021: $481 · 2022: $422 · 2023: $651 · 2024: $1,533 · 2025: $3,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859 · Travel and Lodging: $1,801 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,858.83 |
| Travel and Lodging | $1,801.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,500.42 | 2023-2025 | Indigo System, Penumbra System |
| Medtronic Vascular, INC. | $1,422.54 | 2019-2020 | |
| Boston Scientific Corporation | $984.91 | 2019-2025 | Watchman Flx |
| Abiomed | $215.37 | 2019-2023 | Impella |
| Pfizer INC. | $197.16 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $178.71 | 2019-2023 | Farxiga |
| Inari Medical, INC. | $178.58 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $166.56 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.15 | 2019-2024 | Lifevest |
| Medtronic, INC. | $133.93 | 2021-2025 | Symplicity G3, Resolute Onyx |
| Amgen INC. | $131.79 | 2019-2021 | |
| Cvrx, INC. | $103.03 | 2024 | Barostim Neo System |
| Abbott Laboratories | $93.14 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $84.54 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $75.44 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $65.43 | 2023-2024 | Na, Nuvision Ice Catheter |
| Philips North America LLC | $64.13 | 2024-2025 | Ecc Solutions, (Ck4) Mcot |
| Terumo Medical Corporation | $44.00 | 2021-2025 | Tr Band |
| Regeneron Healthcare Solutions, INC. | $43.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $42.49 | 2019-2023 | |
| Cordis US Corp. | $30.68 | 2022 | |
| Bracco Diagnostics INC. | $22.72 | 2020 | |
| Irhythm Technologies, INC. | $16.91 | 2021 | |
| Esperion Therapeutics, INC. | $16.25 | 2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $15.24 | 2023 | Assure Wcd |
| Scpharmaceuticals INC. | $14.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Baldasare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.